GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
109 hedge funds and large institutions have $34.4M invested in Sanofi Contingent Value Rights in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
50% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 20
Holders
109
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.48M | |
| 2 | +$438K | |
| 3 | +$385K | |
| 4 |
ACM
Akanthos Capital Management
Woodland Hills,
California
|
+$115K |
| 5 |
PC
Permanens Capital
New York
|
+$19.4K |
Top Sellers
| 1 | -$61.8K | |
| 2 | -$43K | |
| 3 | -$42.6K | |
| 4 |
TI
Telemetry Investments
New York
|
-$23K |
| 5 |
TL
TowerView LLC
New York
|
-$17.2K |